2. Segment Information and Concentrations

12 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Segment Information and Concentrations

The Company views its operations as three segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors and laboratory and pharmacy balances and scales (“Benchtop Laboratory Equipment Operations”), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (“Catalyst Research Instruments Operations”) and the design and marketing of bioprocessing systems and products and related royalty income (“Bioprocessing Systems”).

Segment information is reported as follows:

	Benchtop  Laboratory  Equipment		Catalyst  Research  Instruments			Bioprocessing  Systems			Corporate  and  Other			Consolidated
June 30, 2020:
Revenues	$	6,783,600	$	785,900		$	1,000,800		$	-		$	8,570,300
Foreign Sales		2,589,800		586,500			1,000,400			-			4,176,700
Income (Loss) From Operations		449,700		(472,800	)		(727,500	)		(385,700	)		(1,136,300	)
Assets		12,232,600		1,149,800			546,100			868,900			14,797,400
Long-Lived Asset Expenditures		36,000		-			40,700			-			76,700
Depreciation and Amortization		116,900		1,300			42,700			-			160,900

	Benchtop  Laboratory  Equipment		Catalyst  Research  Instruments			Bioprocessing  Systems		Corporate  and  Other		Consolidated
June 30, 2019:
Revenues	$	7,078,800	$	1,814,900		$	1,306,100	$	-	$	10,199,800
Foreign Sales		2,680,300		1,102,300			1,301,200		-		5,083,800
Income (Loss) From Operations		449,800		(130,600	)		365,000		91,900		776,100
Assets		5,280,700		1,443,200			790,100		762,000		8,276,000
Long-Lived Asset Expenditures		194,500		2,200			15,700		-		212,400
Depreciation and Amortization		217,800		1,000			38,500		-		257,300